- Article
2 Citations
782 Views
3 Pages
Canadian Institutes of Health [...]
- 3.4Impact Factor
- 4.9CiteScore
- 23 daysTime to First Decision
- Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Current Oncology, Volume 14, Issue 3
2007 June - 6 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles (6)
- Article
49 Citations
1,564 Views
7 Pages
The National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: An International Breast Cancer Prevention Trial
- H. Richardson,
- D. Johnston,
- J. Pater and
- P. Goss
Several large phase iii trials have demonstrated that tamoxifen—and more recently, raloxifene—can effectively reduce the incidence of invasive breast cancer by 50%. However, these selective estrogen receptor modulators can also be associated with sev...
- Article
33 Citations
1,901 Views
14 Pages
Alemtuzumab in Chronic Lymphocytic Leukemia
- G. Fraser,
- C.A. Smith,
- K. Imrie,
- R. Meyer and
- The Hematology Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
Questions: (1) With respect to outcomes such as survival, response rate, response duration, time to progression, and quality of life, is alemtuzumab a beneficial treatment option for patients with B-cell chronic lymphocytic leukemia (CLL)? (2) What t...
- Article
96 Citations
2,505 Views
8 Pages
Canadian Recommendations for the Treatment of Glioblastoma Multiforme
- W.P. Mason,
- R. Del Maestro,
- D. Eisenstat,
- P. Forsyth,
- D. Fulton,
- N. Laperrière,
- D. Macdonald,
- J. Perry,
- B. Thiessen and
- The Canadian GBM Recommendations Committee
Recommendation 1: Management of patients with glioblastoma multiforme (GBM) should be highly individualized and should take a multidisciplinary approach involving neuro-oncology, neurosurgery, radiation oncology, and pathology, to optimize treatment...
- Article
16 Citations
1,188 Views
5 Pages
In medicine, assigning priorities for original ideas and for first implementation of a new type of treatment or technology—radium afterloading, for example—is often difficult. This situation is certainly true for radium therapy, with conflicting clai...
- Editorial
678 Views
1 Page
In this Issue of Current Oncology
- M. McLean
The Editorial Board is pleased to announce that Current Oncology is now included in the U.S. National Library of Medicine’s PubMed search engine. [...]
Curr. Oncol. - ISSN 1718-7729